½ÃÀ庸°í¼­
»óǰÄÚµå
1408995

¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2032³â)

Global Cerebrovascular Imaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 244 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³úÇ÷°ü À̹Ì¡ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2022³â 225¾ï 6,000¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 337¾ï 9,000¸¸ ´Þ·¯ °¡±î¿î ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ÀÎ 2023-2030³â CAGRÀº 5.18%ÀÔ´Ï´Ù.

³úÇ÷°ü À̹Ì¡Àº ³úÇ÷°üÀ» ½Ã°¢È­ÇÏ°í Æò°¡Çϱâ À§ÇÑ ´Ù¾çÇÑ ¿µ»ó ±â¼úÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ´Â ³ú¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â µ¿¸Æ°ú Á¤¸ÆÀ» Æ÷ÇÔÇÑ ³úÇ÷°ü°è¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁúȯÀ» Áø´ÜÇÏ°í Æò°¡ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

³úÇ÷°ü À̹Ì¡ ½ÃÀåÀº ³úÇ÷°ü¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â »óŸ¦ Æò°¡Çϰí Áø´ÜÇϱâ À§ÇÑ °í±Þ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇÏ´Â ´Ù¾çÇÑ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ³úÁ¹Áß°ú µ¿¸Æ·ù¸¦ Æ÷ÇÔÇÑ ³úÇ÷°ü ÁúȯÀÇ ¹ßº´·ü Áõ°¡·Î ÀÎÇØ Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ ¿µ»ó Áø´ÜÀÇ Çʿ伺ÀÌ ´ëµÎµÇ°í ÀÖ´Â °ÍÀÌ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ±â¼ú ¹ßÀüÀº ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ÇöÀç ÁøÇà ÁßÀÎ °³¹ß·Î ÀÎÇØ ¿µ»ó Áø´Ü ¹æ½ÄÀÌ °­È­µÇ¾î ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿Í ȯÀÚ¿¡°Ô ´õ¿í ¸Å·ÂÀûÀ¸·Î ´Ù°¡°¥ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. °í·ÉÈ­µµ ½ÃÀå ¼ºÀå¿¡ Å« ±â¿©¸¦ Çϰí Àִµ¥, °í·ÉÀÚ´Â ³úÇ÷°ü Áúȯ¿¡ °É¸± À§ÇèÀÌ ³ô±â ¶§¹®ÀÔ´Ï´Ù. Á¶±â ¹ß°ß ¹× Á¶±â °³ÀÔ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ³úÇ÷°ü ¿µ»ó ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿µ»ó ±â¼ú¿¡¼­ ÀΰøÁö´ÉÀÇ ÅëÇÕÀº Áø´ÜÀÇ Á¤È®¼º°ú È¿À²¼ºÀ» Çâ»ó½ÃÄÑ ÀÌ ºÐ¾ß¿¡¼­ Áß¿äÇÑ ÁøÀüÀ» º¸À̰í ÀÖ½À´Ï´Ù.

Á¶»ç ¸®Æ÷Æ®´Â Porter's Five Forces ¸ðµ¨, ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» äÅÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÅøÀº ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇϰí, ¼¼°è ·¹º§¿¡¼­ÀÇ °æÀï ¸Å·ÂÀ» Æò°¡Çϴµ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ ÅøÀº ¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼öµµ ÀÖ½À´Ï´Ù. ³úÇ÷°ü À̹Ì¡ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ÀüüÀûÀÎ ¾îÇÁ·ÎÄ¡¸¦ Á¦°øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

º» ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ³úÇ÷°ü À̹Ì¡ ½ÃÀåÀÇ ÇöÀç¿Í ÇâÈÄ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¾ÖÇø®ÄÉÀÌ¼Ç ºÎ¹®ÀÇ ¼ö¿ä, ÃßÁ¤¡¤¿¹Ãø¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ¿ä±¸»çÇ×ÀÌ ÀÖ´Â °æ¿ì, ¹®ÀÇÇØÁֽñ⠹ٶø´Ï´Ù. ¸®¼­Ä¡ÆÀÀÌ °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ½º³À¼ô

Á¦3Àå ³úÇ÷°ü À̹Ì¡ : »ê¾÷ ºÐ¼®

  • ¼­·Ð : ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀÌ¾î ¸®½ºÆ®
  • ¸¶ÄÉÆÃ Ã¤³Î
    • ´ÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ÀδÙÀÌ·ºÆ® ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå ºÐ¼® : ±â¼úº°

  • °³¿ä : ±â¼úº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ±â¼úº°
  • Àڱ⠰ø¸í Ç÷°üÁ¶¿µ
  • ³úÆÄ
  • ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ
  • ÀÚ±â°ø¸í¿µ»ó¹ý
  • °æµ¿¸Æ ÃÊÀ½ÆÄ
  • ³úÇ÷°üÁ¶¿µ

Á¦6Àå ¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå ºÐ¼® : ¿ëµµº°

  • °³¿ä : ¿ëµµº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ¿ëµµº°
  • Áø´Ü
  • Ä¡·á
  • Ç÷°ü ±âÇü
  • Àϰú¼º ³úÇãÇ÷¹ßÀÛ
  • µ¿¸Æ·ù
  • ³úÁ¹Áß

Á¦7Àå ¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°

  • °³¿ä : ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ºÐ¼® : ÃÖÁ¾»ç¿ëÀÚº°
  • ¿µ»ó Áø´Ü ¼¾ÅÍ
  • º´¿ø
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ³úÇ÷°ü À̹Ì¡ ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼­·Ð
  • ºÏ¹ÌÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÆÇ¸Å ºÐ¼®
    • °³¿ä¡¤½ÇÀû¡¤¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ³úÇ÷°ü À̹Ì¡ ±â¾÷ÀÇ °æÀï ±¸µµ

  • ³úÇ÷°ü À̹Ì¡ ½ÃÀåÀÇ °æÀï
  • Á¦ÈÞ/Çù¾÷/ÇÕÀÇ
  • ÇÕº´¡¤Àμö
  • ½ÅÁ¦Ç° ¹ß¸Å
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ °³¿ä

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Esaote
  • Fujifilm Holdings
  • Carestream Health
  • Shimadzu Corporation
  • Koninklijke Philips N.V.
  • Samsung Medison Co. Ltd.
  • Hitachi Medical Systems
  • Toshiba medical Systems Corporation
  • Siemens Healthcare GmbH
  • GE Healthcare
KSA 24.01.25

The global demand for Cerebrovascular Imaging Market is presumed to reach the market size of nearly USD 33.79 BN by 2030 from USD 22.56 BN in 2022 with a CAGR of 5.18% under the study period 2023 - 2030.

Cerebrovascular imaging involves the use of various imaging techniques to visualize and assess the blood vessels in the brain. It is crucial in diagnosing and evaluating conditions affecting the cerebrovascular system, which includes the arteries and veins supplying blood to the brain.

MARKET DYNAMICS

The cerebrovascular imaging market is propelled by a convergence of factors addressing the increasing demand for advanced diagnostic tools in assessing and diagnosing conditions affecting the blood vessels in the brain. A key driver is the rising incidence of cerebrovascular diseases, including strokes and aneurysms, necessitating accurate and timely diagnostic imaging. Technological advancements play a pivotal role, with ongoing developments enhancing imaging modalities, making them more attractive for healthcare providers and patients. The aging population contributes significantly to market growth, given the higher risk of cerebrovascular diseases in elderly individuals. Increased awareness related to early detection and intervention further drives the demand for cerebrovascular imaging services. The integration of artificial intelligence in imaging technologies enhances diagnostic accuracy and efficiency, marking a significant advancement in the field.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cerebrovascular imaging. The growth and trends of cerebrovascular imaging industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cerebrovascular imaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Magnetic Resonance Angiogram
  • Electroencephalogram
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Carotid Ultrasound
  • Cerebral Angiography

By Application

  • Diagnostic
  • Therapeutic
  • Vascular Malformation
  • Transient Ischemic Attack
  • Aneurysm
  • Stroke

By End-User

  • Diagnostic Imaging Centers
  • Hospitals
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cerebrovascular Imaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cerebrovascular Imaging market include Esaote, Fujifilm Holdings, Carestream Health, Shimadzu Corporation, Koninklijke Philips N.V., Samsung Medison Co., Ltd., Hitachi Medical Systems, Toshiba medical Systems Corporation, Siemens Healthcare GmbH, and GE Healthcare. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . CEREBROVASCULAR IMAGING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CEREBROVASCULAR IMAGING MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Magnetic Resonance Angiogram Historic and Forecast Sales by Regions
  • 5.5 Electroencephalogram Historic and Forecast Sales by Regions
  • 5.6 Computed Tomography Historic and Forecast Sales by Regions
  • 5.7 Magnetic Resonance Imaging Historic and Forecast Sales by Regions
  • 5.8 Carotid Ultrasound Historic and Forecast Sales by Regions
  • 5.9 Cerebral Angiography Historic and Forecast Sales by Regions

6 . GLOBAL CEREBROVASCULAR IMAGING MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Diagnostic Historic and Forecast Sales by Regions
  • 6.5 Therapeutic Historic and Forecast Sales by Regions
  • 6.6 Vascular Malformation Historic and Forecast Sales by Regions
  • 6.7 Transient Ischemic Attack Historic and Forecast Sales by Regions
  • 6.8 Aneurysm Historic and Forecast Sales by Regions
  • 6.9 Stroke Historic and Forecast Sales by Regions

7 . GLOBAL CEREBROVASCULAR IMAGING MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Diagnostic Imaging Centers Historic and Forecast Sales by Regions
  • 7.5 Hospitals Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL CEREBROVASCULAR IMAGING MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE CEREBROVASCULAR IMAGING COMPANIES

  • 9.1. Cerebrovascular Imaging Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF CEREBROVASCULAR IMAGING INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Esaote
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Fujifilm Holdings
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Carestream Health
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Shimadzu Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Koninklijke Philips N.V.
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Samsung Medison Co. Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. Hitachi Medical Systems
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Toshiba medical Systems Corporation
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Siemens Healthcare GmbH
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. GE Healthcare
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦